SCIENCE: Voice in Friedreich ataxia

The relationship between dysphonia and dysarthria in FRDA suggests that reducing overall dysphonia severity via therapeutic techniques that improve phonatory stability and increase speaking rate is a viable target for clinical trials.

 

Click here for more details.

Tags: , , ,

Related Post

Redenlab shines in Huberman Podcast, unveiling cannabis study and speech analysis expertise

  • Posted on 27 April, 2023
    MEDIA RELEASERedenlab, a leading techbio company, proudly announces its recent feature on the highly acclaimed Huberman Podcast. The podcast episode...
    Read more

    The L16HTHOUSE Study

    • Posted on 30 March, 2023
      L16HTHOUSE is a research trial testing an experimental medication for treating speech, motor, learning, and other developmental delays in children...
      Read more

      Dietary fat supplement trial for A-T

      • Posted on 30 March, 2023
        Ataxia telangiectasia (A-T) is a rare inherited condition that affects the nervous and immune systems. A-T typically impacts movement, vision...
        Read more